Since activation of the erbB3 signaling plays an important role in the development of trastuzumab resistance [26], we next studied whether MM-121 might overcome the resistance and enhance trastuzumab-mediated growth inhibition in two otherwise resistant breast cancer cell lines. Here, ERBB3 is linked to breast cancer.